{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:09:20Z","timestamp":1782169760813,"version":"3.54.5"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Intrathecal baclofen (ITB) therapy, a viable alternative for unsuitable candidates of conventional spasticity medications, is a preferred method of administration over the oral route. Owing to its enhanced bioavailability, ITB ensures a more effective delivery at the target site.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>There is a lack of conclusive evidence regarding the use of ITB treatment in managing ambulatory patients with spastic dystonia. Before ITB pump implantation, patients commonly undergo an ITB bolus injection trial to rule out potential adverse reactions and verify the therapeutic effects on hypertonic issues. In this report, we highlight a case of spastic dystonia, particularly focusing on an ambulatory patient who demonstrated significant improvement in both the modified Ashworth scale (MAS) score and gait pattern following the ITB injection trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>This case report outlines the medical history of a 67-year-old male diagnosed with left-side hemiplegia and spastic dystonia, resulting from his second episode of intracranial hemorrhage in the right thalamus. An ITB injection trial was initiated because the patient was not suitable for continued botulinum toxin injections and oral medications. This was due to the persistent occurrence of spastic dystonia in both the upper and lower extremities. The patient underwent a four-day ITB injection trial with progressively increasing doses, resulting in improved MAS scores and gait parameters, including cadence, step length, step time, stride length, and stride time were increased. Particularly, kinematic gait analysis demonstrates a substantial improvement of increased knee flexion in the swing phase in stiff knee gait pattern. These findings indicated a gradual reduction in spasticity-related symptoms, signifying the positive effect of the ITB injection trial. The patient eventually received an ITB pump implantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this post-stroke patient with spastic dystonia, ITB therapy has demonstrated effective and substantial management of spasticity, along with improvement in gait patterns.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1330811","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:39:07Z","timestamp":1707885547000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Intrathecal baclofen therapy improved gait pattern in a stroke patient with spastic dystonia"],"prefix":"10.3389","volume":"15","author":[{"given":"Kyung Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Kwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seok","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Ji","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jelekin.2017.09.005","article-title":"Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia","volume":"37","author":"Marinelli","year":"2017","journal-title":"J Electromyogr Kinesiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/10749357.2018.1474422","article-title":"Effect of oral baclofen on spasticity poststroke: responders versus non-responders","volume":"25","author":"Mizuno","year":"2018","journal-title":"Top Stroke Rehabil"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e17272","DOI":"10.7759\/cureus.17272","article-title":"Dystonia as a presenting feature of acute ischemic stroke: a case report and literature review","volume":"13","author":"Roman Casul","year":"2021","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt","year":"1988","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/mds.25567","article-title":"The focal dystonias: current views and challenges for future research","volume":"28","author":"Jinnah","year":"2013","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/S1353-8020(11)70050-5","article-title":"Dystonia: phenomenology","volume":"18","author":"LeDoux","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/mus.20285","article-title":"Pathophysiology of spastic paresis. II: emergence of muscle overactivity","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.pmr.2015.07.003","article-title":"Spasticity management after stroke","volume":"26","author":"Bethoux","year":"2015","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1017\/S0012162201001190","article-title":"Intrathecal baclofen for generalized dystonia","volume":"43","author":"Albright","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/ana.410170202","article-title":"Antispasticity drugs: mechanisms of action","volume":"17","author":"Davidoff","year":"1985","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1517\/14656560903426171","article-title":"Treatment strategies for dystonia","volume":"11","author":"Cloud","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40265-018-1042-z","article-title":"Botulinum toxin type a for the treatment of lower limb spasticity after stroke","volume":"79","author":"Santamato","year":"2019","journal-title":"Drugs"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/cmdc.201900594","article-title":"Repurposing of FDA-approved drugs for treating iatrogenic botulism: a paired 3D-QSAR\/docking approach(dagger)","volume":"15","author":"Floresta","year":"2020","journal-title":"ChemMedChem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00702-021-02312-4","article-title":"Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity","volume":"128","author":"Dressler","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport((R))), OnabotulinumtoxinA (Botox((R))), and IncobotulinumtoxinA (Xeomin((R))) neurotoxin content and potential implications for duration of response in patients","volume":"10","author":"Field","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2340\/16501977-2211","article-title":"Efficacy and safety of oral baclofen in the management of spasticity: a rationale for intrathecal baclofen","volume":"49","author":"Ertzgaard","year":"2017","journal-title":"J Rehabil Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-211-33079-1_2","article-title":"Intrathecal baclofen in the treatment of spasticity","volume":"97","author":"Dykstra","year":"2007","journal-title":"Acta Neurochir Suppl"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-211-33079-1_31","article-title":"Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state","volume":"97","author":"Taira","year":"2007","journal-title":"Acta Neurochir Suppl"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/0883073818785074","article-title":"Intrathecal baclofen therapy-practical approach: clinical benefits and complication management","volume":"33","author":"Winter","year":"2018","journal-title":"J Child Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(85)90228-4","article-title":"Continuous intrathecal baclofen for severe spasticity","volume":"2","author":"Penn","year":"1985","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2023.11.PEDS23473","article-title":"Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study","author":"Abdelmageed","year":"2023","journal-title":"J Neurosurg Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/sj.sc.3101928","article-title":"Spasticity-assessment: a review","volume":"44","author":"Biering-Sorensen","year":"2006","journal-title":"Spinal Cord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.rehab.2019.06.004","article-title":"Motion analysis for the evaluation of muscle overactivity: a point of view","volume":"62","author":"Roche","year":"2019","journal-title":"Ann Phys Rehabil Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.clinph.2019.01.012","article-title":"Spastic dystonia in stroke subjects: prevalence and features of the neglected phenomenon of the upper motor neuron syndrome","volume":"130","author":"Trompetto","year":"2019","journal-title":"Clin Neurophysiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/jor.1100070611","article-title":"Repeatability of kinematic, kinetic, and electromyographic data in normal adult gait","volume":"7","author":"Kadaba","year":"1989","journal-title":"J Orthop Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.apmr.2004.11.013","article-title":"Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury","volume":"86","author":"Horn","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MOP.0000000000000567","article-title":"Management of hypertonia in cerebral palsy","volume":"30","author":"Nahm","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1191\/1352458506ms1232sr","article-title":"Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients","volume":"12","author":"Ben Smail","year":"2006","journal-title":"Mult Scler"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2106\/00004623-199610000-00008","article-title":"Gait pattern in the early recovery period after stroke","volume":"78","author":"De Quervain","year":"1996","journal-title":"J Bone Joint Surg Am"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0021-9290(95)00144-1","article-title":"The influence of muscles on knee flexion during the swing phase of gait","volume":"29","author":"Piazza","year":"1996","journal-title":"J Biomech"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12984-020-00724-z","article-title":"Rectus femoris hyperreflexia contributes to stiff-knee gait after stroke","volume":"17","author":"Akbas","year":"2020","journal-title":"J Neuroeng Rehabil"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0966-6362(97)00040-4","article-title":"The modelling of adult spastic paretic stiff-legged gait swing period based on actual kinematic data","volume":"7","author":"Kerrigan","year":"1998","journal-title":"Gait Posture"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/1744-1633.12308","article-title":"Blessing or burden? Long-term maintenance, complications and clinical outcome of intrathecal baclofen pumps","volume":"22","author":"Chan","year":"2018","journal-title":"Surg Pract"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/088307380001500201","article-title":"Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial","volume":"15","author":"Gilmartin","year":"2000","journal-title":"J Child Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e7472","DOI":"10.1097\/MD.0000000000007472","article-title":"Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury","volume":"96","author":"Yoon","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-211-33079-1_25","article-title":"Intrathecal baclofen for the treatment of spasticity","volume":"97","author":"Dones","year":"2007","journal-title":"Acta Neurochir Suppl"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1330811\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:39:09Z","timestamp":1707885549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1330811\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":36,"alternative-id":["10.3389\/fneur.2024.1330811"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1330811","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"article-number":"1330811"}}